Bruce Spinowitz

5.9k total citations
84 papers, 2.8k citations indexed

About

Bruce Spinowitz is a scholar working on Nephrology, Pulmonary and Respiratory Medicine and Hematology. According to data from OpenAlex, Bruce Spinowitz has authored 84 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Nephrology, 30 papers in Pulmonary and Respiratory Medicine and 29 papers in Hematology. Recurrent topics in Bruce Spinowitz's work include Dialysis and Renal Disease Management (25 papers), Erythropoietin and Anemia Treatment (25 papers) and Potassium and Related Disorders (20 papers). Bruce Spinowitz is often cited by papers focused on Dialysis and Renal Disease Management (25 papers), Erythropoietin and Anemia Treatment (25 papers) and Potassium and Related Disorders (20 papers). Bruce Spinowitz collaborates with scholars based in United States, Australia and Germany. Bruce Spinowitz's co-authors include Steven Fishbane, Pablo E. Pérgola, Chaim Charytan, Simon D. Roger, Edgar V. Lerma, David Packham, Mikhail Kosiborod, Philip T. Lavin, Bradley J. Maroni and Volker H. Haase and has published in prestigious journals such as New England Journal of Medicine, JAMA and Diabetes.

In The Last Decade

Bruce Spinowitz

80 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bruce Spinowitz United States 24 983 897 734 446 411 84 2.8k
Anjay Rastogi United States 27 557 0.6× 1.0k 1.1× 366 0.5× 139 0.3× 387 0.9× 114 2.4k
Lucia Del Vecchio Italy 34 581 0.6× 2.4k 2.7× 1.2k 1.6× 63 0.1× 426 1.0× 175 4.0k
David Packham Australia 24 963 1.0× 821 0.9× 63 0.1× 462 1.0× 614 1.5× 70 2.6k
Yoshiharu Tsubakihara Japan 40 551 0.6× 3.1k 3.5× 1.3k 1.8× 56 0.1× 588 1.4× 143 4.9k
Jacek Małyszko Poland 27 364 0.4× 956 1.1× 616 0.8× 51 0.1× 369 0.9× 163 2.6k
Noémie Jourde‐Chiche France 29 508 0.5× 1.5k 1.7× 349 0.5× 57 0.1× 248 0.6× 122 3.7k
Simon D. Roger Australia 30 1.1k 1.1× 1.1k 1.2× 1.4k 1.9× 524 1.2× 626 1.5× 88 3.7k
Yasushi Asano Japan 33 520 0.5× 1.4k 1.5× 469 0.6× 49 0.1× 473 1.2× 167 3.3k
Giuseppe Coppolino Italy 29 522 0.5× 1.8k 2.1× 181 0.2× 75 0.2× 518 1.3× 142 3.5k
Peter van der Meer Netherlands 45 824 0.8× 489 0.5× 1.5k 2.0× 412 0.9× 3.9k 9.5× 171 6.8k

Countries citing papers authored by Bruce Spinowitz

Since Specialization
Citations

This map shows the geographic impact of Bruce Spinowitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruce Spinowitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruce Spinowitz more than expected).

Fields of papers citing papers by Bruce Spinowitz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bruce Spinowitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruce Spinowitz. The network helps show where Bruce Spinowitz may publish in the future.

Co-authorship network of co-authors of Bruce Spinowitz

This figure shows the co-authorship network connecting the top 25 collaborators of Bruce Spinowitz. A scholar is included among the top collaborators of Bruce Spinowitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bruce Spinowitz. Bruce Spinowitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fishbane, Steven, Martin L. Ford, Masafumi Fukagawa, et al.. (2022). Potassium responses to sodium zirconium cyclosilicate in hyperkalemic hemodialysis patients: post-hoc analysis of DIALIZE. BMC Nephrology. 23(1). 59–59. 7 indexed citations
2.
Fishbane, Steven, David M. Charytan, Glenn M. Chertow, et al.. (2021). Consensus-Based Recommendations for the Management of Hyperkalemia in the Hemodialysis Setting. Journal of Renal Nutrition. 32(4). e1–e14. 10 indexed citations
3.
4.
Fishbane, Steven, Bruce Spinowitz, Wayne Wisemandle, & Nancy Martin. (2019). Randomized Controlled Trial of Subcutaneous Epoetin Alfa-epbx Versus Epoetin Alfa in End-Stage Kidney Disease. Kidney International Reports. 4(9). 1235–1247. 4 indexed citations
5.
Spinowitz, Bruce, Roberto Pecoits‐Filho, Wolfgang C. Winkelmayer­, et al.. (2019). Economic and quality of life burden of anemia on patients with CKD on dialysis: a systematic review. Journal of Medical Economics. 22(6). 593–604. 45 indexed citations
6.
Roger, Simon D., Bruce Spinowitz, Edgar V. Lerma, et al.. (2019). Efficacy and Safety of Sodium Zirconium Cyclosilicate for Treatment of Hyperkalemia: An 11-Month Open-Label Extension of HARMONIZE. American Journal of Nephrology. 50(6). 473–480. 54 indexed citations
7.
Rossing, Peter, Geoffrey A. Block, Melanie Chin, et al.. (2019). Effect of bardoxolone methyl on the urine albumin-to-creatinine ratio in patients with type 2 diabetes and stage 4 chronic kidney disease. Kidney International. 96(4). 1030–1036. 30 indexed citations
8.
Fishbane, Steven & Bruce Spinowitz. (2018). Update on Anemia in ESRD and Earlier Stages of CKD: Core Curriculum 2018. American Journal of Kidney Diseases. 71(3). 423–435. 181 indexed citations
9.
Chertow, Glenn M., Gerald B. Appel, Geoffrey A. Block, et al.. (2018). Effects of bardoxolone methyl on body weight, waist circumference and glycemic control in obese patients with type 2 diabetes mellitus and stage 4 chronic kidney disease. Journal of Diabetes and its Complications. 32(12). 1113–1117. 11 indexed citations
10.
Pérgola, Pablo E., et al.. (2016). Vadadustat, a novel oral HIF stabilizer, provides effective anemia treatment in nondialysis-dependent chronic kidney disease. Kidney International. 90(5). 1115–1122. 184 indexed citations
11.
McCullough, Peter A., Maria Rosa Costanzo, Marc T. Silver, et al.. (2015). Novel Agents for the Prevention and Management of Hyperkalemia. Reviews in Cardiovascular Medicine. 16(2). 140–155. 15 indexed citations
12.
Macdougall, Iain C., Robert Provenzano, Amit Sharma, et al.. (2013). Peginesatide for Anemia in Patients with Chronic Kidney Disease Not Receiving Dialysis. New England Journal of Medicine. 368(4). 320–332. 78 indexed citations
13.
14.
Spinowitz, Bruce, Annamaria T. Kausz, Jovanna Baptista, et al.. (2008). Ferumoxytol for Treating Iron Deficiency Anemia in CKD. Journal of the American Society of Nephrology. 19(8). 1599–1605. 207 indexed citations
15.
Wolfson, Marsha, Bruce Spinowitz, Michael J. Germain, & Robert L. Benz. (2007). 238. American Journal of Kidney Diseases. 49(4). B84–B84. 3 indexed citations
16.
Goldfarb‐Rumyantzev, Alexander S., Michael H. Schwenk, Samuel Liu, Chaim Charytan, & Bruce Spinowitz. (2003). Prediction of Single‐Pool Kt/V Based on Clinical and Hemodialysis Variables Using Multilinear Regression, Tree‐Based Modeling, and Artificial Neural Networks. Artificial Organs. 27(6). 544–554. 6 indexed citations
17.
Blumenfield, Michael, Nicolas Lévy, Bruce Spinowitz, et al.. (1997). Fluoxetine in Depressed Patients on Dialysis. The International Journal of Psychiatry in Medicine. 27(1). 71–80. 90 indexed citations
18.
Charytan, Chaim, et al.. (1996). Fractional direct dialysis quantification: A new approach for prescription and monitoring hemodialysis therapy. Kidney International. 50(6). 1845–1849. 15 indexed citations
19.
Gupta, Bharat, Bruce Spinowitz, Chaim Charytan, & Samuel J. Wahl. (1993). Cholesterol Crystal Embolization-Associated Renal Failure After Therapy With Recombinant Tissue-Type Plasminogen Activator. American Journal of Kidney Diseases. 21(6). 659–662. 25 indexed citations
20.
Spinowitz, Bruce & J. A. Zadunaisky. (1979). Action of adenosine on chloride active transport of isolated frog cornea. American Journal of Physiology-Renal Physiology. 237(2). F121–F127. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anjay Rastogi Breakdown of academic impact, for papers by Lucia Del Vecchio Breakdown of academic impact, for papers by David Packham Breakdown of academic impact, for papers by Yoshiharu Tsubakihara Breakdown of academic impact, for papers by Jacek Małyszko Breakdown of academic impact, for papers by Noémie Jourde‐Chiche Breakdown of academic impact, for papers by Simon D. Roger Breakdown of academic impact, for papers by Yasushi Asano Breakdown of academic impact, for papers by Giuseppe Coppolino Breakdown of academic impact, for papers by Peter van der Meer
Rankless by CCL
2026